Cookies used for improved website experience

Siemens Healthineers and our partners use cookies and other similar technologies to operate the Siemens Healthineers websites and personalize content and ads. You may find out more about how we use cookies by clicking "Show details" or by referring to our Cookie Policy.
You may allow all cookies or select them individually. And you may change your consent and cookie preferences anytime by clicking on the "Review and change your consent" button on the Cookie Policy page.

When you visit Siemens Healthineers websites, we use different types of cookies and other similar technologies to, for example, personalize content and ads, store your preferences, analyze traffic to our website, or offer social media features. We also share information about your use of our websites with our partners for social media, advertising, and analytics.
You can select which cookies should be stored when you use our websites. You can change your cookie settings and consent anytime by clicking on the "click to review and change your consent" button on the Cookie Policy website.
For more information, please refer to the "Show details" button and our Cookie Policy.


Your consent applies to the following domains: mtr-symposium.event.siemens-healthineers.com, live.hemostasis-institute.event.siemens-healthineers.com, hemostasis-institute.event.siemens-healthineers.com, mrinsightsinrt.event.siemens-healthineers.com, breast-imaging-world.event.siemens-healthineers.com, cardiovascularwebinars.event.siemens-healthineers.com, live.cardiovascularwebinars.event.siemens-healthineers.com, events.siemens-healthineers.com, fleet.siemens-healthineers.com, landingpages.siemens-healthineers.com, www.ith-icoserve.com, forum.siemens-healthineers.com, csx-meta.siemens-healthineers.com, csx-pi.siemens-healthineers.com, cs-pi.siemens-healthineers.com, jobs.siemens-healthineers.com, www.clinistix.siemens-healthineers.com, www.medicalaffairs.siemens-healthineers.com, www.clinitest.siemens-healthineers.com, www.cspartnerportal.siemens-healthineers.com, www.magnetomworld.siemens-healthineers.com, www.medmuseum.siemens-healthineers.com, www.oem-products.siemens-healthineers.com, www.siemens-healthineers.com

KariéraCOVID-19
  1. Siemens Healthineers Slovakia
  2. Laboratórna diagnostika
  3. Molecular Diagnostics
  4. Molecular Diagnostics Tests & Reagents
  5. FTD CE-IVD Assays: Infectious Disease Testing
SRS

Clinically Relevant Targets, Better ResultsSyndromic Testing for Infectious Diseases 

Syndromic testing allows clinicians to rapidly test for a broad number of pathogens in patients that present with overlapping signs and symptoms. Siemens Healthineers offers real-time PCR multiplex assays for infectious disease testing with pathogens grouped according to clinical relevance to syndromes such as respiratory infections, gastroenteritis, childhood infections, and meningitis.

These real-time PCR multiplex kits, grouped according to clinical syndromes, serve an important clinical need. With this approach physicians can order a single test from the lab covering multiple probable pathogenic causes—virus, bacteria or parasite. Syndromic testing can save time, resources, reagents, and be more cost-effective while providing a fast and accurate clinical diagnosis for the physician who must make treatment decisions for the patient.

Features & Benefits

greater efficiency icon

Greater Efficiency

  • Real-time PCR multiplex kits for infectious disease detection based on syndromic testing
  • Comprehensive diagnostic approach to a clinical syndrome
  • Faster diagnosis with better informed therapeutic decisions
  • Cost-effective testing strategy
lower costs icon

Lower Costs

  • Single multiplex real-time PCR kit for multiple targets that are grouped according to syndrome
  • Saves the laboratory time, resources, reagents, and budget 
better outcomes icon

Better Outcomes

  • Clinically relevant testing for appropriately grouped targets based on a patient’s signs and symptoms
  • Improved patient outcomes due to a faster clinical diagnosis and appropriate treatment decisions

Assays

FTD SARS-CoV-2 Assay*

One-tube singleplex assay for the detection of the human coronavirus SARS-CoV-2 and internal control.

FTD SARS-CoV-2/FluA/FluB/HRSV Assay**

For the detection of five respiratory viruses from one sample eluate: SARS-CoV-2, Influenza A virus, Influenza B virus, and human Respiratory Syncytial Viruses A/B.

FTD Respiratory pathogens 21 Assay**

Five-tube multiplex assay for the detection of influenza A virus; influenza A(H1N1) virus (swine-lineage); influenza B virus; human rhinovirus; human coronaviruses NL63, 229E, OC43 and HKU1; human parainfluenza viruses 1, 2, 3 and 4; human metapneumoviruses A/B; human bocavirus; human respiratory syncytial viruses A/B; human adenovirus; enterovirus; human parechovirus; Mycoplasma pneumoniae and internal control.

FTD FLU/HRSV Assay**

One-tube multiplex assay for detection of influenza A virus; influenza B virus; respiratory syncytial viruses A/B and internal control.

FTD Vesicular rash Assay**

One-tube multiplex assay for detection of herpes simplex viruses 1 and 2; varicella zoster virus and internal control.

FTD Stool parasites Assay**

One-tube multiplex assay for the detection of Entamoeba histolytica; Cryptosporidium spp.; Giardia lamblia and internal control.

FTD Viral meningitis Assay**

Two-tube multiplex assay for detection of herpes simplex viruses 1 and 2; varicella zoster virus; mumps virus; enterovirus; human parechovirus and internal control.

Siemens Healthineers has a solution for your molecular diagnostics testing laboratory.

*CE-IVD labeled for diagnostic use in the EU. This test has not been FDA-cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21. U.S.C. § 360bbb- 3(b)(1), unless the authorization is terminated or revoked sooner.

** CE-IVD labeled for diagnostic use in the EU.